Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab plus GEMOX in advanced biliary tract cancer
NCT01216345Phase 2Completed
- Sponsor
- Association of Research on the Biology of Liver Tumors
- Start
- Oct 2006
- Primary completion
- Oct 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in biliary tract cancer (BTC), sponsored by Association of Research on the Biology of Liver Tumors. Started Oct 2006; status: completed.
02
Drugs
KL-140
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT01216345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216345.